Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage

被引:833
作者
Giorgi, JV
Hultin, LE
McKeating, JA
Johnson, TD
Owens, B
Jacobson, LP
Shih, R
Lewis, J
Wiley, DJ
Phair, JP
Wolinsky, SM
Detels, R
机构
[1] Univ Calif Los Angeles, Sch Med, Dept Med Cellular Immunol & Cytometry, Multictr AIDS Cohort Study, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Sch Med, Dept Med, Multictr AIDS Cohort Study, Los Angeles, CA 90095 USA
[3] Univ Calif Los Angeles, Sch Med, Dept Biomath, Multictr AIDS Cohort Study, Los Angeles, CA 90095 USA
[4] Univ Calif Los Angeles, Sch Med, AIDS Res Ctr, Multictr AIDS Cohort Study, Los Angeles, CA 90095 USA
[5] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90095 USA
[6] Univ Reading, Sch Anim & Microbial Sci, Reading RG6 2AJ, Berks, England
[7] Johns Hopkins Univ, Sch Hyg & Publ Hlth, Baltimore, MD 21205 USA
[8] Northwestern Univ, Sch Med, Dept Med, Chicago, IL 60611 USA
关键词
D O I
10.1086/314660
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To define predictors of survival time in late human immunodeficiency virus type 1 (HIV-1) disease, long- and short-duration survivors were studied after their CD4(+) T cells fell to less than or equal to 50/mm(3). Immune activation of CD4(+) and CD8(+) T cells, as measured by elevated cell surface expression of CD38 antigen, was strongly associated with shorter subsequent survival (P less than or equal to.002), The naive CD45RA(+)CD62L(+) T cell reserve was low in all subjects and did not predict survival (P=.34 for CD4(+) and .08 for CD8(+) cells). Higher virus burden correlated with CD8(+) but not CD4(+) cell activation and, after correcting for multiple comparisons, was not associated with shorter survival (P=.02), All of the patients' viruses used CCR5, CXCR4, or both, and coreceptor usage did not predict survival (P=.27), Through mechanisms apparently unrelated to higher virus burden, immune activation is a major determinant of survival in advanced HIV-1 disease.
引用
收藏
页码:859 / 870
页数:12
相关论文
共 75 条
  • [61] In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression
    Scarlatti, G
    Tresoldi, E
    Bjorndal, A
    Fredriksson, R
    Colognesi, C
    Deng, HK
    Malnati, MS
    Plebani, A
    Siccardi, AG
    Littman, DR
    Fenyo, EM
    Lusso, P
    [J]. NATURE MEDICINE, 1997, 3 (11) : 1259 - 1265
  • [62] LOW T-CELL RESPONSIVENESS TO ACTIVATION VIA CD3/TCR IS A PROGNOSTIC MARKER FOR ACQUIRED-IMMUNODEFICIENCY-SYNDROME (AIDS) IN HUMAN IMMUNODEFICIENCY VIRUS-1 (HIV-1)-INFECTED MEN
    SCHELLEKENS, PTA
    ROOS, MTL
    DEWOLF, F
    LANGE, JMA
    MIEDEMA, F
    [J]. JOURNAL OF CLINICAL IMMUNOLOGY, 1990, 10 (02) : 121 - 127
  • [63] SENSITIVE METHOD FOR MEASURING APOPTOSIS AND CELL-SURFACE PHENOTYPE IN HUMAN THYMOCYTES BY FLOW-CYTOMETRY
    SCHMID, I
    UITTENBOGAART, CH
    GIORGI, JV
    [J]. CYTOMETRY, 1994, 15 (01): : 12 - 20
  • [64] BIOLOGICAL PHENOTYPE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 CLONES AT DIFFERENT STAGES OF INFECTION - PROGRESSION OF DISEASE IS ASSOCIATED WITH A SHIFT FROM MONOCYTOTROPIC TO T-CELL-TROPIC VIRUS POPULATIONS
    SCHUITEMAKER, H
    KOOT, M
    KOOTSTRA, NA
    DERCKSEN, MW
    DEGOEDE, REY
    VANSTEENWIJK, RP
    LANGE, JMA
    SCHATTENKERK, JKME
    MIEDEMA, F
    TERSMETTE, M
    [J]. JOURNAL OF VIROLOGY, 1992, 66 (03) : 1354 - 1360
  • [65] Early and late HIV-1 RNA level and its association with other markers and disease progression in long-term AIDS-free homosexual men
    Spijkerman, IJB
    Prins, M
    Goudsmit, J
    Veugelers, PJ
    Coutinho, RA
    Miedema, F
    deWolf, F
    [J]. AIDS, 1997, 11 (11) : 1383 - 1388
  • [66] Predictors of survival in HIV-infected persons with 50 or fewer CD4 cells/mm(3)
    Spino, C
    Kahn, JO
    Dolin, R
    Phair, JP
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1997, 15 (05): : 346 - 355
  • [67] Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1
    Stanley, SK
    Ostrowski, MA
    Justement, JS
    Gantt, K
    Hedayati, S
    Mannix, M
    Roche, K
    Schwartzentruber, DJ
    Fox, CH
    Fauci, AS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (19) : 1222 - 1230
  • [68] ACTIVATION OF VIRUS-REPLICATION AFTER VACCINATION OF HIV-1-INFECTED INDIVIDUALS
    STAPRANS, SI
    HAMILTON, BL
    FOLLANSBEE, SE
    ELBEIK, T
    BARBOSA, P
    GRANT, RM
    FEINBERG, MB
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (06) : 1727 - 1737
  • [69] TAYLOR JMG, 1989, J ACQ IMMUN DEF SYND, V2, P114
  • [70] CD4(+) T-CELL NUMBER AT THE TIME OF ACQUIRED-IMMUNODEFICIENCY-SYNDROME
    TAYLOR, JMG
    SY, JP
    VISSCHER, B
    GIORGI, JV
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1995, 141 (07) : 645 - 651